8,456 peer-reviewed studies, each with a short note written from its published abstract: what kind of study it was, who took part, what was measured and what the authors reported. Observational studies show associations, not proof.
2025 / Parallel 2-arm cluster randomized intervention trial
Eighty healthy omnivorous young adults (40 cohabitating pairs) were randomized to consume 3 weekly servings of either fresh beef and lamb or plant-based meat alternatives within an ovo-lacto vegetarian diet for 10 weeks. Thirty-nine pairs completed the trial. There were no significant differences between groups in changes from baseline for psychological outcomes or the majority of circulatory markers. Differences between groups were observed for changes in vitamin B12 status and three neurotransmitter-related compounds (adenosine, agmatine, and tyrosine) from baseline to week 10.
Conner TS, Gillies NA, Worthington A, et al. Curr Dev Nutr, 2025. PMID 39723334
2024 / Multicenter randomized controlled trial
A 1:1 randomized controlled trial evaluated the effects of a 20-week intensive multidomain lifestyle intervention versus a wait-list usual care control group in 51 patients with mild cognitive impairment or early dementia due to Alzheimer's disease. After 20 weeks, significant between-group differences favored the intervention group in CGIC (p = 0.001), CDR-SB (p = 0.032), and CDR Global (p = 0.037), with borderline significance for ADAS-Cog (p = 0.053). The intervention group improved on CGIC, CDR Global, and ADAS-Cog and had significantly less progression on CDR-SB, while the control group worsened on all four measures. Plasma Aβ42/40 ratio increased in the intervention group and decreased in controls (p = 0.003), and the microbiome improved only in the intervention group (p < 0.0001).
Ornish D, Madison C, Kivipelto M, et al. Alzheimers Res Ther, 2024. PMID 38849944
2023 / Randomized controlled trial
Sixty-nine tinnitus patients aged 40-70 were randomized to receive placebo (n=22), Ginkgo biloba (60 mg twice daily) alone (n=24), or Ginkgo biloba combined with antioxidants (n=23) across 14 weeks. Supplementation with Ginkgo biloba plus antioxidants produced marked improvement (p<0.05) in post-treatment THI and VAS scores compared to Ginkgo alone and placebo. The greatest percent differences pre- and post-treatment in the combination group were -36% for THI and -22.6% for VAS (p<0.05), alongside significant improvements in various SF-36 quality-of-life parameters.
Chauhan B, Arya S, Chauhan K J Audiol Otol, 2023. PMID 36710418
2023 / Randomized, double-blind, controlled clinical trial
Sixty patients with Alzheimer's disease were randomized to receive either 500 mg/day spirulina twice daily or placebo for 12 weeks. Compared with placebo, spirulina significantly improved MMSE score (+0.30 ± 0.99 vs. -0.38 ± 1.06, p = 0.01). Spirulina also reduced hs-CRP (-0.17 ± 0.29 vs. +0.05 ± 0.27 mg/L, p = 0.006), fasting glucose (-4.56 ± 7.93 vs. +0.80 ± 2.95 mg/dL, p = 0.002), insulin (-0.37 ± 0.62 vs. +0.12 ± 0.40 μIU/mL, p = 0.001), and insulin resistance (-0.08 ± 0.13 vs. 0.03 ± 0.08, p = 0.001), while increasing insulin sensitivity (+0.003 ± 0.005 vs. -0.001 ± 0.003, p = 0.003).
Tamtaji OR, Heidari-Soureshjani R, Asemi Z, et al. Phytother Res, 2023. PMID 36861852
2023 / Cross-sectional study and pilot trial
Researchers evaluated relationships between vitamin B12 status and physical measures of peripheral neuropathy in 38 vegetarian or vegan adults aged 19-40 years, and conducted a small pilot trial of vitamin B12 supplementation. Overall, 26% of participants had deficient or marginal vitamin B12 status (serum vitamin B12 <221 pmol/L). Participants with adequate vitamin B12 status scored 10% higher on the Purdue pegboard assembly test and 20% higher on the left hand adjusted functional dexterity test compared to those with marginal-to-deficient status (p < 0.05).
NANO counterpoint →
Arnold T, Johnston CS Front Nutr, 2023. PMID 38174111
2023 / Randomized, double-blind, placebo-controlled 3-arm comparative trial
A 6-month randomized, double-blind, placebo-controlled study evaluated 48 subjects with moderate Alzheimer's disease dementia assigned to 400 mg twice daily of placebo, unformulated standard curcumin complex, or bioavailable CurQfen-curcumin (CGM). Supplementation with CGM led to significant improvements (P < 0.05) in Mini-Mental State Examination (MMSE) and Geriatric Locomotive Function Scale (GLFS) scores in both intra- and inter-group comparisons. Analysis of serum biomarkers (BDNF, Aβ42, tau protein, IL-6, and TNF-α) also demonstrated significant improvement (P < 0.05) in the CGM group compared to both placebo and unformulated curcumin.
Das SS, Gopal PM, Thomas JV, et al. Front Dement, 2023. PMID 39081970
2022 / Double-blind, placebo-controlled randomized crossover trial
Following a 2-week diet avoiding artificial food coloring (AFC), 18 college students with ADHD and 11 controls were randomized to a double-blind, placebo-controlled crossover challenge receiving 225 mg AFC or placebo disguised in cookies for 3 days each week. In the ADHD group, the AFC challenge led to increased posterior mean gamma power (p = 0.05), decreased posterior relative alpha power (p = 0.04), and a marginal increase in inattentive symptoms (p = 0.08). No effects of AFC were observed in the control group. The authors note that larger studies are needed to confirm these findings.
Kirkland AE, Langan MT, Holton KF Nutr Neurosci, 2022. PMID 32116139
2022 / Randomized, placebo-controlled clinical trial
A randomized, placebo-controlled trial evaluated the effects of 100 mg of açaí extract for three months versus placebo in 30 individuals with chronic tinnitus. The açaí group experienced a reduction in tinnitus discomfort assessed via the Tinnitus Handicap Inventory (p = 0.006). Significant differences in common anxiety disorder symptoms were observed in the placebo group (p = 0.016), but no significant differences were observed for oxidative metabolism biomarkers, although values decreased post-treatment in all groups.
Oppitz SJ, Garcia MV, Bruno RS, et al. Codas, 2022. PMID 35107519
2022 / Double-blind randomized phase I clinical trial
A double-blind phase I trial evaluated oral nicotinamide riboside (NR; 1,000 mg daily) versus placebo for 30 days in 30 newly diagnosed, treatment-naive Parkinson's disease patients. NR was well tolerated and caused a significant, though variable, increase in cerebral NAD levels and related CSF metabolites. Patients with increased brain NAD levels showed altered cerebral metabolism that was linked to mild clinical improvement. NR also upregulated processes linked to mitochondrial, lysosomal, and proteasomal function in blood and/or muscle, and lowered inflammatory cytokines in serum and CSF.
Brakedal B, Dölle C, Riemer F, et al. Cell Metab, 2022. PMID 35235774
2022 / Randomized, double-blind, placebo-controlled crossover trial
A randomized, double-blind, placebo-controlled crossover trial evaluated the effect of consuming 75 mg of resveratrol twice daily for three months versus placebo in 62 hormonal migraineurs. Outcomes included the hormonal migraine burden index (HMBI), Headache Impact Test-6™, Migraine Disability Assessment, and Migraine-Specific Quality of Life. No significant differences were observed between resveratrol and placebo for HMBI (p = 0.895) or any secondary disability and quality-of-life measures.
Dzator JSA, Howe PRC, Coupland KG, et al. Nutrients, 2022. PMID 35565731
2021 / Phase 1 double-blind randomized placebo-controlled trial
Twenty men with alcohol use disorder-related cirrhosis were randomized 1:1 to receive a single placebo or fecal microbiota transplant (FMT) enema from a donor enriched in Lachnospiraceae and Ruminococcaceae. At day 15, craving was reduced in 90% of the FMT group versus 30% in placebo (P = 0.02), accompanied by lower urinary ethylglucuronide/creatinine (P = 0.03), improved cognition and psychosocial quality of life, reduced IL-6, and increased microbial diversity and butyrate/isobutyrate. Over 6 months, patients with serious adverse events (SAEs) were significantly higher in placebo compared to FMT (8 vs. 2, P = 0.02), as were AUD-related SAEs (7 vs. 1, P = 0.02).
Bajaj JS, Gavis EA, Fagan A, et al. Hepatology, 2021. PMID 32750174
2001 / Review
This article introduces the concept of jet lag among travelers. It raises questions regarding the nature of jet lag, whether melatonin is safe or acts as a sleeping pill, and how light therapy relates to melatonin. No specific experimental results or conclusions are provided in the abstract.
Lathrop NJ, Lentz M Air Med J, 2001. PMID 11552110
2001 / Narrative review
This review discusses studies examining the effect of early infant feeding on cognitive and visual development. In reviewed studies, standard formula-fed infants showed lower tissue accretion of long-chain polyunsaturated fatty acids (AA, EPA, DHA) and lower visual and neurodevelopmental test scores compared to breast-fed infants. The authors note that the mechanisms require elucidation and highlight challenges regarding dietary lipid mixtures during the introduction of solid foods.
Shows an association, not proof of cause and effect.
Agostoni C, Giovannini M Nutr Health, 2001. PMID 12003083
1999 / Narrative review
This review evaluates essential fatty acid requirements in vegetarians during pregnancy, lactation, and infancy. A fetus obtains LCPUFAs via selective uptake from maternal plasma, and LCPUFAs are present in vegetarian breast milk, with no evidence that vegetarians have a limited capacity to synthesize LCPUFAs. Compared with omnivores, vegetarians show greater proportions of n-6 LCPUFAs and lower proportions of n-3 LCPUFAs, with lower DHA observed in blood and artery phospholipids of vegetarian infants. Primate experiments showed altered visual function with a high ratio of linoleic acid to alpha-linolenic acid, raising concerns about excessive linoleic acid intake.
NANO counterpoint →
Sanders TA Am J Clin Nutr, 1999. PMID 10479231
1999 / Narrative review
This review evaluates findings linking diet to the development of Alzheimer's disease (AD) in light of literature published after Grant's earlier work. Recent epidemiologic studies have supported that dietary fat and energy in old age are high risk factors, whereas fish and cereals serve as risk-reduction factors. The author notes that diet may contribute to AD through modulating oxidative stress and inflammation.
Shows an association, not proof of cause and effect.
NANO counterpoint →
Grant WB J Alzheimers Dis, 1999. PMID 12214118
1998 / Narrative review
Omega-3 and omega-6 essential fatty acids compete for the same metabolic enzymes. Gross deficiencies of both omega-6 and omega-3 have been observed in humans receiving lipid-free total parenteral nutrition (TPN), while omega-3 deficiency specifically has been induced by TPN high in omega-6 and low in omega-3 fatty acids. Across natural human populations, omega-6 and omega-3 proportions show an inverse correlation. Additionally, significant deficits of omega-3 essential fatty acids have been measured in humans suffering from neuropathy or immune system impairment.
Holman RT J Nutr, 1998. PMID 9478042
1997 / Narrative review
Fatigue from sleep loss, shift work, and long duty cycles impairs alertness and performance in aviators. The review notes that adequate sleep is the only cure for fatigue. Pilots can improve sleep habits through self-administered relaxation therapy, soothing bedtime routines, and avoiding specific activities and substances before sleep. Prophylactic naps can help sustain performance when adequate sleep is not feasible due to work factors.
Caldwell JA Aviat Space Environ Med, 1997. PMID 9327120
1996 / Literature review
This review documents literature published between 1976 and 1995 on the acute mood alterations resulting from single sessions of exercise. It covers experimental design, operational definitions of mood, and ecological validity. Results indicate that single bouts of exercise may offer acute mood benefits to both clinical and nonclinical populations, while potential mechanisms and research recommendations are also reviewed.
Yeung RR J Psychosom Res, 1996. PMID 8778396
1993 / Regulatory hazard assessment review
This regulatory assessment evaluated lead exposure and its adverse effects across different populations. Blood lead levels as low as 10 micrograms/dl were associated with impaired neurobehavioural and cognitive development, electrophysiological deficits in children, and reduced gestational age and birth weight in infants. In adults, blood lead levels of 30 micrograms Pb/dl were linked to elevated blood pressure and other adverse effects. Ingestion levels producing these concern levels were estimated at 60 micrograms/day for children <=6 years, 150 micrograms/day for children >=7 years, 250 micrograms/day for pregnant women, and 750 micrograms/day for adults.
Shows an association, not proof of cause and effect.
Carrington CD, Sheehan DM, Bolger PM Food Addit Contam, 1993. PMID 8359314
1992 / Narrative review
Persistent organochlorines like PCBs, DDT, and dioxins accumulate in human adipose tissue and cross from pregnant women to fetuses. Food accounts for 80 percent of human contamination, with meat, fish, dairy, and commercial fruit cited as primary sources. Children born to mothers at the high end of the exposure curve show neurobehavioral deficits, including short-term memory loss. Wildlife and laboratory animals exposed to organochlorines also display behavioral changes.
Shows an association, not proof of cause and effect.
Hall RH Nutr Health, 1992. PMID 1603449
1990 / Narrative review
This review discusses the impact of nutritional status on susceptibility to lead toxicity, focusing on dietary factors of substantial clinical importance. Subtle neurobehavioral and cognitive effects of lead exposure are noted as major concerns, though subtle changes in susceptibility are hard to evaluate under overwhelming exposure. Nutrition is highlighted as an adjunct to primary environmental lead reduction strategies.
Mahaffey KR Environ Health Perspect, 1990. PMID 2088758
1988 / Review
This article discusses the possible involvement of environmental aluminum in the etiology of Alzheimer disease and senile dementia of the Alzheimer type. The hypothesis is supported by direct and indirect relationships between certain encephalopathies and the abnormal presence of aluminum(III) in human and animal brain tissues. Proposals for further biochemical, toxicological, and analytical work are illustrated.
Shows an association, not proof of cause and effect.
Zatta P, Giordano R, Corain B, et al. Med Hypotheses, 1988. PMID 3412205
1985 / Review
Prejudice against obese persons is evident in children as young as 6 years old, alongside discrimination in academic and work settings. Despite this, overweight individuals in the general population and those seen for medical or surgical procedures generally show no greater psychological disturbance or psychopathology than non-obese individuals. Serious psychiatric disturbances linked to obesity include body image disparagement and negative emotional reactions to dieting, with dieting potentially contributing to increased bulimia incidence. Women, adolescent girls, and the morbidly obese appear to suffer the most deleterious consequences of societal contempt.
Wadden TA, Stunkard AJ Ann Intern Med, 1985. PMID 4062126
1982 / Review and case reports
This review discusses methylmercury as a potent neurotoxic environmental pollutant. Human exposure occurs through eating contaminated fish or inadvertent misuse of grain treated with the poison as a fungicide. Major epidemics have occurred in Japan, Iraq, Pakistan, Guatemala, and Ghana, with sporadic incidents in the United States and Canada. There is currently no effective antidote to counteract its effects on the central nervous system.
Elhassani SB J Toxicol Clin Toxicol, 1982. PMID 6763633